SPG20 Antikörper (Internal Region)
-
- Target Alle SPG20 Antikörper anzeigen
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SPG20 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunofluorescence (IF)
- Aufreinigung
- SPARTIN antibody was purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Immunogen
- SPARTIN antibody was raised against a 15 amino acid synthetic peptide near the internal region of SPARTIN.
- Top Product
- Discover our top product SPG20 Primärantikörper
-
-
- Applikationshinweise
- ELISA: Antibody detection limit dilution 1:8000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 500 μg/mL
- Buffer
- Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20 °C.
-
- Target
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
- Andere Bezeichnung
- SPARTIN (SPG20 Produkte)
- Synonyme
- SPARTIN antikoerper, TAHCCP1 antikoerper, AI840044 antikoerper, C79168 antikoerper, mKIAA0610 antikoerper, spartin antikoerper, Spg20 antikoerper, spg20a antikoerper, zgc:172059 antikoerper, spg20b antikoerper, zgc:153766 antikoerper, spartin antikoerper, spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) antikoerper, spartin a antikoerper, spartin b antikoerper, SPART antikoerper, Spg20 antikoerper, Spart antikoerper, sparta antikoerper, spartb antikoerper
- Gen-ID
- 23111
- NCBI Accession
- NP_055902
- UniProt
- Q8N0X7
- Pathways
- Regulation of Cell Size, SARS-CoV-2 Protein Interaktom
-